Healthcare | May 05, 2026
OBESITAS 2026 concludes with focus on India’s rising obesity burden
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Lifts full-year outlook as obesity drug boom accelerates
But acquisition charges drag earnings into loss
The Danish biotech company confirmed the global study will begin in the second half of 2026
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The launch coincides with IBS Awareness Month in April
Subscribe To Our Newsletter & Stay Updated
